These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7030443)

  • 1. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M; Middlemiss DN; Yates RA
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
    Peet M; Bethell MS; Coates A; Khamnee AK; Hall P; Cooper SJ; King DJ; Yates RA
    Br J Psychiatry; 1981 Aug; 139():105-11. PubMed ID: 7030442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.
    Yorkston NJ; Zaki SA; Weller MP; Gruzelier JH; Hirsch SR
    Acta Psychiatr Scand; 1981 Jan; 63(1):13-27. PubMed ID: 7015789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY; Busch DA; Fang VS
    Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
    Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
    Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol as an adjunct to the treatment of schizophrenia.
    Yorkston NJ; Zaki SA; Pitcher DR; Gruzelier JH; Hollander D; Sergeant HG
    Lancet; 1977 Sep; 2(8038):575-8. PubMed ID: 71397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in serum-prolactin after propranolol in schizophrenia.
    Hanssen T; Heyden T; Sundberg I; Wetterberg L; Eneroth P
    Lancet; 1978 Jan; 1(8055):101-2. PubMed ID: 74547
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
    Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
    Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
    King DJ; Turkson SN; Liddle J; Kinney CD
    Br J Psychiatry; 1980 Nov; 137():458-68. PubMed ID: 7008891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.